Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01375023
What this trial is testing

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 3
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Large-scale testing (Phase 3)Ended earlyNCT00714259
What this trial is testing

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Who this might be right for
Multiple MyelomaCLL / SLLNon Hodgkin's Lymphoma+2 more
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05357482
What this trial is testing

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

Who this might be right for
Sickle Cell AnemiaBeta Thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT02133196
What this trial is testing

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung CancerSquamous Cell CarcinomaAdvanced NSCLC+2 more
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)Study completedNCT04339101
What this trial is testing

Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

Who this might be right for
Acute LeukemiaHematologic and Lymphocytic DisorderMyelodysplastic Syndrome+2 more
City of Hope Medical Center 59
Large-scale testing (Phase 3)UnknownNCT00224614
What this trial is testing

Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia

Who this might be right for
Leukemia, Myeloid, Acute
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)UnknownNCT00604136
What this trial is testing

Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy

Who this might be right for
Metastatic Melanoma
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)UnknownNCT03412409
What this trial is testing

RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

Who this might be right for
Acute LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 50
Large-scale testing (Phase 3)Study completedNCT01854567
What this trial is testing

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma+1 more
Mesoblast, Ltd. 49
Not applicableEnded earlyNCT02049424
What this trial is testing

Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow

Who this might be right for
Hematologic Malignancy
Istituto Clinico Humanitas 9
Testing effectiveness (Phase 2)Study completedNCT01511562
What this trial is testing

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 113
Testing effectiveness (Phase 2)Ended earlyNCT01622556
What this trial is testing

Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Virginia 6
Testing effectiveness (Phase 2)Study completedNCT01814475
What this trial is testing

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
Gruppo Italiano Trapianto di Midollo Osseo 62
Very early researchEnded earlyNCT00881556
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa
Columbia University 3
Testing effectiveness (Phase 2)Ended earlyNCT00354172
What this trial is testing

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)Temporarily pausedNCT01929239
What this trial is testing

Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning

Who this might be right for
Monitor Adverse Events
Roger Williams Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT02435901
What this trial is testing

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Who this might be right for
Sickle Cell DiseaseBeta Thalassemia-Major
Northwell Health 29